TECHNOLOGY & DIAGNOSTICS IN PAPHOS
Technology supports better care when it helps answer a meaningful clinical question. At the practice, diagnostic and treatment systems are used to support more precise assessment, more confident treatment selection, and more consistent follow-up across vision care, dry eye, and eyelid care.
The focus is not equipment for its own sake. Imaging, measurement, and testing are selected when they improve understanding of the problem, help distinguish between similar causes of symptoms, or make follow-up more reliable over time.
This is especially relevant in conditions such as glaucoma, retinal disease, dry eye, and eyelid problems where management depends on careful baseline assessment and change over time.
General ophthalmic assessment may include automated refraction, keratometry, slit-lamp examination, and tonometry. These tools support routine eye care as well as the initial assessment of more specific complaints.
Biometry and ultrasound-based measurements may also be used when additional anatomical information is needed.
Glaucoma care relies on more than eye pressure alone. Assessment may include optic nerve examination, OCT imaging, corneal thickness measurement, and visual field testing.
Where appropriate, glaucoma assessment may include the iCare COMPASS, which combines fundus-tracked visual field testing, retinal imaging, and eye tracking in a single examination.
Retinal care often depends on imaging that helps document the macula, optic nerve, and retinal structure with greater precision than examination alone. This is particularly relevant in conditions such as macular degeneration, diabetic eye disease, retinal vein occlusion, and glaucoma follow-up.
The value of retinal imaging is often greatest when findings can be compared over time rather than viewed in isolation. In patients receiving retinal injections, imaging helps document disease activity and treatment response, supporting clinical treatment planning.
Dry eye evaluation may include tear film analysis, non-invasive assessment of tear break-up, ocular surface imaging, and meibomian gland assessment. These tools help clarify whether symptoms are being driven mainly by tear instability, aqueous deficiency, gland dysfunction, inflammation, or a mixed picture.
Where useful, advanced anterior segment imaging and epithelial mapping can also help assess corneal surface irregularity, document subtle surface change, and support more precise follow-up.
In the periocular area, technology also supports treatment as well as diagnosis. This includes the authentic PLEXR Plus plasma device for selected non-surgical eyelid and superficial lesion indications, and in-office thermal pulsation treatment when meibomian gland dysfunction remains an important driver of dry eye symptoms.
The role of each treatment system depends on patient selection, anatomy, and the clinical problem being addressed.
Related care
Glaucoma assessment depends on structured testing, imaging, and long-term comparison of results.
Dry eye evaluation may combine tear film, gland, and ocular surface assessment to clarify the main driver of symptoms.
Retina care and intravitreal injection planning use imaging to distinguish stable findings from active disease that needs closer review or treatment.
Thermal pulsation for MGD and dry eye is an example of in-office technology used when blocked oil glands remain clinically important.
Eyelid and periocular care, including non-surgical tightening, PLEXR plasma wrinkle reduction, and selected lesion treatment, depends on careful periocular assessment and appropriate patient selection.
The purpose is not to showcase equipment for its own sake, but to explain how imaging, measurement, and testing can support more precise diagnosis, treatment selection, and follow-up.
No. Testing is selected according to the clinical question. Some visits need only standard examination, while others benefit from imaging, ocular surface analysis, visual field testing, ultrasound, or structured follow-up measurements.
In dry eye, diagnostic tools can help assess tear film stability, aqueous deficiency, inflammation, and meibomian gland structure. In glaucoma, they can help evaluate the optic nerve, measure change over time, and combine visual field testing with imaging where appropriate.